Physician

Daniel Armando Rodriguez, M.D.

According to 2025 Medicare claims, Daniel Rodriguez, M.D. (NPI: 1982960175) practices allergy/immunology in the New York-Jersey City-White Plains, NY-NJ market, with the plurality of this provider's patient population coming from Bergen, NJ. This provider's primary affiliated billing organization is MPV NEW JERSEY MD SERVICES PC (NPI: 1215391271; TIN: 462906928) and primary practice location at 07458-3057. Rodriguez is affiliated with the JFK Population Health LLC, JFK Health ACO (ACO ID: A2311), participating under the MSSP model.

Rodriguez's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 123 traditional Medicare patients, billed 1,125 HCPCS/CPT codes, and received $24,909 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 588 prescription claims across 151 beneficiaries totaling $140,939 in drug costs, led by Xolair (Omalizumab). 2017 DME data shows 48 claims. Open Payments data shows 97 records totaling $1,920. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $11,749 to $24,909. Similarly, Part D prescription costs have moved sharply higher in recent years, from $1,924 to $140,939. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	74	624	$11,749
2020	60	180	$6,414
2021	59	402	$11,743
2022	111	803	$20,554
2023	98	577	$20,302
2024	123	1,125	$24,909

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	N/R	19	$1,924
2017	N/R	12	$1,291
2018	56	183	$23,040
2019	93	318	$33,044
2020	69	280	$34,644
2021	84	306	$62,694
2022	129	549	$83,961
2023	133	606	$123,843
2024	151	588	$140,939

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	48	$43,128
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	42	50	$106
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	28	28	$102
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	56	72	$75
94010	Test to measure expiratory airflow and volume	42	54	$25
95004	Test for allergy using allergenic extract	21	415	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xolair	Omalizumab	17	413	$52,071
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	780	$16,279
Breo Ellipta	Fluticasone/Vilanterol	17	540	$6,738
Advair Hfa	Fluticasone Propion/Salmeterol	18	540	$6,316
Arnuity Ellipta	Fluticasone Furoate	14	420	$2,954

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	97	$1,920	GENZYME CORPORATION
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Armando Rodriguez, M.D.?

Tedicare shows public-source Medicare data for Daniel Armando Rodriguez, M.D. (NPI 1982960175), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Armando Rodriguez, M.D. have ACO affiliation data?

Daniel Armando Rodriguez, M.D. is shown with ACO affiliation data for JFK Population Health LLC, JFK Health ACO (MSSP, ACO ID A2311).

What billing organization is linked to Daniel Armando Rodriguez, M.D.?

Daniel Armando Rodriguez, M.D. is linked to MPV NEW JERSEY MD SERVICES PC (billing NPI 1215391271) in the available physician profile data.

Does Daniel Armando Rodriguez, M.D. have Open Payments data?

Daniel Armando Rodriguez, M.D. has 97 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.